Maria Shipkova

 

 

  • 2018 – Medical Head Therapeutic Drug Monitoring, Synlab Holding Germany GmbH, MVZ Leinfelden-Echterdingen with teaching appointment at University of Tübingen
  • 2003 -2018 – Senior scientist and Head TDM/Tox Section, Institute of Clinical Chemistry and Laboratory Medicine, Klinikum Stuttgart, Germany
  • 1999- 2002 – Resident Dept. of Clinical Chemistry, University Göttingen, Germany
  • 1995-1999 – Postdoctoral fellow, Dept. of Clinical Chemistry, University Göttingen, Germany
  • 1992-1995 – Resident Dept. of Clinical Chemistry, University Sofia, Bulgaria
  • 1991-1992 – Resident Dept. Internal Medicine, University Sofia, Bulgaria

Academic Degrees:

  • Dr. med. University Göttingen, Germany, 2002
  • D-r (BG)., University Sofia, Bulgaria, 1990

Professional Registrations:

  • Fellow European Board of Laboratory Medicine/Medical Biopathology (F.E.B.L.M./M.B.), 2013
  • Clinical Pathology Consultant, 1996

Professional Society Memberships:

  • Vereinte Deutsche Gesellschaft für Laboratoriumsmedizin und Klinische Chemie (DGKL)
  • International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
  • Transplantation Society
  • Bulgarian Academy of Sciences and Arts

Publications:

  • 166 publications contributed to scientific journals and books on the following topics: therapeutic drug monitoring, drug metabolism, drug toxicity, development and evaluation of analytical methods, organ function tests, biomarkers of drug effects

Stipends and Awards:

  • 2015 Grant from the Federal Ministry of Education and Research “Validation of GcfDNA based diagnostic test to detect organ damage after kidney transplantation”
  • 2011 Grant of the Pathobiochemistry and Molecular Diagnostics Foundation, DGKL, Analytical validation of biomarker assays in transplantation medicine
  • 2005 Young Investigator Award of the International Society for Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
  • 2004 Grant of the Pathobiochemistry and Molecular Diagnostics Foundation, DGKL, Acyl glucoronides of mycophenolic acid
  • 2002 Grant of the University Göttingen, Germany, Acyl glucuronide of mycophenolic acid
  • 1998 Stipend Volkswagen Foundation, Germany, Metabolism of immunosuppressants
  • 1996 Stipend Otvoreno Obschtestvo, Bulgaria, Pharmacokinetics of Taxol
  • 1995 Tempus Phare stipend of the EU, Therapeutic Drug Monitoring

Varia:

  • Reviews Editor of Therapeutic Drug Monitoring (TDM) (2018 – )
  • Secretary IATDMCT (2017 -2021)
  • Director of Education IATDMCT (2015 – 2017)
  • Vice-Chair IATDMCT Communication Committee (2011 – 2017) and member of the Communication Committee till 2019
  • Member of the IATDMCT Biomarkers in transplantation Working Group (2009 – )
  • Coordinator “TDM of Everolimus” Consensus Project (2013-2016)
  • Past-Chair of the IATDMCT Immunosuppressive Drugs Scientific Committee (2013–2015)
  • Past Editor in Chief of the IATDMCT Newsletter “Compass” (2009 – 2015)
  • Member of the LOC of the 11th IATDMCT Congress, 2011, Stuttgart, Germany
  • Member of the Editorial Boards of Journal of Laboratory Medicine